Billionaire Druckenmiller Bets Big on Healthcare Stock Natera

Stanley Druckenmiller is taking a surprising route with his latest investment strategy. While many investors are pouring money into artificial intelligence, his Duquesne Family Office is doubling down on the healthcare sector. The firm now holds Natera, a specialized genomics company, as its largest single stock position.

Natera has been a massive success for the billionaire investor. The firm began buying shares in 2022 when they traded between $35 and $50. Today, the stock sits near $328, marking a gain of nearly ten times the original investment. This position now accounts for roughly 17 percent of his family office holdings.

The company is seeing strong growth in its specialized testing services. In the second quarter alone, Natera processed over one million tests. Revenue climbed 38 percent compared to the prior year, leading management to raise their full year expectations significantly.

While Druckenmiller still holds tech giants like Amazon and Alphabet, he has moved away from certain AI plays. He previously sold his stake in Nvidia due to valuation concerns. Traders are now watching his move into healthcare as a potential signal that some big players are shifting their focus away from the crowded tech sector.